|
NCOA5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.781700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.641360E-03 |
| Normal-vs-Stage2 |
1.382620E-01 |
| Normal-vs-Stage3 |
7.640400E-01 |
| Normal-vs-Stage4 |
1.304020E-02 |
| Stage1-vs-Stage2 |
9.700800E-01 |
| Stage1-vs-Stage3 |
2.381400E-01 |
| Stage1-vs-Stage4 |
7.051600E-01 |
| Stage2-vs-Stage3 |
3.921600E-01 |
| Stage2-vs-Stage4 |
7.317200E-01 |
| Stage3-vs-Stage4 |
3.186000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.501680E-02 |
| Normal-vs-AfricanAmerican |
8.382900E-03 |
| Normal-vs-Asian |
9.443800E-01 |
| Caucasian-vs-AfricanAmerican |
4.741000E-01 |
| Caucasian-vs-Asian |
1.686230E-01 |
| AfricanAmerican-vs-Asian |
2.939200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.463100E-03 |
| Normal-vs-Female |
3.182800E-01 |
| Male-vs-Female |
2.608400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.490200E-02 |
| Normal-vs-Extreme_Weight |
6.171700E-04 |
| Normal-vs-Obese |
7.561700E-02 |
| Normal-vs-Extreme_Obese |
5.219400E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.201200E-01 |
| Normal_Weight-vs-Obese |
5.336400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.040200E-01 |
| Extreme_Weight-vs-Obese |
2.443800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.705000E-01 |
| Obese-vs-Extreme_Obese |
2.192200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.548600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.545800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.036200E-04 |
| Normal-vs-Age(81-100Yrs) |
4.700500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.141800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.185700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.021500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.903100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.601300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.574000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.906650E-01 |
| Normal-VS-Type2 PRCC |
2.86749999967029E-07 |
| Normal-VS-KIRP CIMP |
5.006600E-04 |
| Normal-VS-Unclassified PRCC |
8.273400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.97470999999672E-05 |
| Type1 PRCC-VS-KIRP CIMP |
7.457600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.940200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.871000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.241600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.589940E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.956200E-03 |
| Normal-vs-N1 |
7.337800E-01 |
| Normal-vs-N2 |
2.4578999999969E-05 |
| N0-vs-N1 |
3.507900E-02 |
| N0-vs-N2 |
1.028980E-01 |
| N1-vs-N2 |
4.903800E-02 |
|
|
